Counteractive role of Terminalia catappa leaf extract on hematological and coagulation disturbance in Type 2 diabetic rats
- PMID: 37766705
- PMCID: PMC10521173
- DOI: 10.14202/vetworld.2023.1593-1599
Counteractive role of Terminalia catappa leaf extract on hematological and coagulation disturbance in Type 2 diabetic rats
Abstract
Background and aim: Diabetes mellitus is a leading cause of mortality worldwide associated with hyperglycemia-induced hematological aberrations and thromboembolic complications. This study aimed to explore the modulatory effect of Terminalia catappa leaf aqueous crude extract (TCLE) on hematological and coagulation disturbances in a Type 2 diabetic rat model.
Materials and methods: High-fat diet streptozotocin-induced diabetic rats were treated orally with 400 and 800 mg/kg body weight TCLE daily for 28 days. Full blood count, coagulation parameters, plasma calcium (Ca), and erythrocyte glycogen (GLYC) levels were assessed using standard procedures.
Results: Terminalia catappa leaf aqueous crude extract treatment had a significant (p < 0.05) prolonging effect on clotting and bleeding times while increasing Ca, GLYC and mean corpuscular volume in diabetic rats. On the other hand, lymphocytes (LYM), platelet (PLT) count, mean PLT volume, neutrophil-LYM ratio (NLR), and PLT-LYM ratio (PLR) of TCLE-treated diabetic animals were significantly reduced (p < 0.05) compared with untreated diabetic animals. Lymphocyte, PLT count, NLR, and PLR correlated positively (p < 0.05) with plasma glucose, while a significant positive association was observed between Ca and GLYC. On the other hand, a strong negative association (p < 0.05) was observed between clotting time and fasting plasma glucose.
Conclusion: These findings suggest that T. catappa leaf extract may be useful in reversing diabetic-mediated hematological anomalies due to its anticoagulant and anti-anemic activities.
Keywords: Terminalia catappa; coagulation; diabetes; hematology; high-fat diet; streptozotocin-induced.
Copyright: © Iheagwam, et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
Terminalia catappa Fruit Extract Reverses Streptozotocin-Induced Diabetic Retinopathy in Rats.Endocr Metab Immune Disord Drug Targets. 2021;21(6):1053-1065. doi: 10.2174/1871530320666201029142113. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33121423
-
Terminalia catappa aqueous extract reduces hyperglycaemia and oxidative stress in diabetic-hypercholesterolemic rats.J Ayurveda Integr Med. 2025 Jan-Feb;16(1):101025. doi: 10.1016/j.jaim.2024.101025. Epub 2025 Jan 18. J Ayurveda Integr Med. 2025. PMID: 39827649 Free PMC article.
-
Toxicological evaluation of aqueous leaf extract of Terminalia catappa linn (combretaceae) in pregnant rats.Pan Afr Med J. 2023 Dec 28;46:118. doi: 10.11604/pamj.2023.46.118.37339. eCollection 2023. Pan Afr Med J. 2023. PMID: 38465010 Free PMC article.
-
Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats.Sci Rep. 2022 Jun 23;12(1):10711. doi: 10.1038/s41598-022-15114-9. Sci Rep. 2022. PMID: 35739183 Free PMC article.
-
Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications.J Pharm Pharmacol. 2017 Feb;69(2):123-134. doi: 10.1111/jphp.12676. Epub 2016 Dec 20. J Pharm Pharmacol. 2017. PMID: 28000229 Review.
References
-
- Agu K.C. Diabetes mellitus:A review of some of the prognostic markers of response to treatment and management. J. Insul. Resist. 2018;3(1):a36.
-
- Kachekouche Y, Dali-Sahi M, Benmansour D, Dennouni-Medjati N. Hematological profile associated with Type 2 diabetes mellitus. Diabetes Metab. Syndr. 2018;12(3):309–312. - PubMed
LinkOut - more resources
Full Text Sources